NDAQ Nasdaq Inc.

Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; iSun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. from The Nasdaq Stock Ma

Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; iSun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. from The Nasdaq Stock Market

NEW YORK, May 31, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock of RiskOn International, Inc. RiskOn International, Inc.’s securities were suspended on February 28, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the warrants of Graphjet Technology (f.k.a., Energem Corp.). Graphjet Technology’s warrants were suspended on March 15, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Agile Therapeutics, Inc. Agile Therapeutics, Inc.’s securities were suspended on March 26, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of NextPlay Technologies, Inc. NextPlay Technologies, Inc.’s securities were suspended on May April 15, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock, units, and warrants of Relativity Acquisition Corp. Relativity Acquisition Corp.’s securities were suspended on May 2, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of iSun, Inc. iSun, Inc.’s securities were suspended on May 23, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares, warrants, and units of Ace Global Business Acquisition Limited. Ace Global Business Acquisition Limited’s securities were suspended on May 24, 2024, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the Class A common stock of Marpai, Inc. Marpai, Inc.’s securities were suspended on May 29, 2024, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at  Nasdaq’s rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: .



EN
31/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nasdaq Inc.

 PRESS RELEASE

Nasdaq Verafin Announces Launch of its Agentic AI Workforce, Deliverin...

Nasdaq Verafin Announces Launch of its Agentic AI Workforce, Delivering a Step Change in AML Compliance Efficiency Suite of digital workers will automate resource-intensive workflows, empowering banks to more effectively fight financial crime NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Nasdaq Verafin today announced the launch of the Agentic AI Workforce, a suite of digital workers that will deliver a step change in the way banks conduct anti-money laundering (AML) compliance by automating low-value, high-volume compliance processes. Building on the successful adoption of its GenAI Enti...

 PRESS RELEASE

Thomson Reuters Corp to Join the Nasdaq-100 Index® Beginning July 28, ...

Thomson Reuters Corp to Join the Nasdaq-100 Index® Beginning July 28, 2025 NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) today announced that Thomson Reuters Corp (Nasdaq: TRI), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, July 28, 2025. Thomson Reuters Corp will replace ANSYS, Inc. (Nasdaq: ANSS) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. ANSYS, Inc. will also be removed from the Nasdaq-100 Tech Sector™ Index (Nasdaq: NDXT™), t...

 PRESS RELEASE

Nasdaq statement on the preliminary proxy filed by Invesco QQQ Trust a...

Nasdaq statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- Today, Nasdaq issued the following statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it. Nasdaq is aware of the preliminary proxy that was filed by Invesco QQQ Trust and the proposals contained within it. Invesco and Nasdaq were engaged in dialogue as Invesco explored bringing these proposals to shareholders. The proposed change to the Trust structure does not alter the terms of Nasdaq’s ...

 PRESS RELEASE

Nasdaq Halts Bowen Acquisition Corp.

Nasdaq Halts Bowen Acquisition Corp. NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted on July 15, 2025 in Bowen Acquisition Corp. at 17:45:19 Eastern Time for additional information requested from the company. The last sale price of the company’s securities was: Ordinary shares (Nasdaq: BOWN) $9.19Rights (Nasdaq: BOWNR) $0.2252Units (Nasdaq: BOWNU) $13.02 Trading will remain halted until Bowen Acquisition Corp. has fully satisfied Nasdaq’s request for additional information. For news and additional information about t...

 PRESS RELEASE

Delisting of Securities from The Nasdaq Stock Market

Delisting of Securities from The Nasdaq Stock Market NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of NKGen Biotech, Inc. NKGen Biotech, Inc.’s securities were suspended on March 5, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that it will delist the common stock, rights, and units of Aquaron Acquisition Corp. Aquaron Acquisition Corp.’s securities were suspended on March 7, 2025 and have not traded on Nasdaq since that time. Nasdaq also announced today that...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch